{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:27:45Z","timestamp":1793824065097,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FCDO\/Wellcome Trust under the Coronavirus Grant","award":["[233705\/Z\/21\/Z]"],"award-info":[{"award-number":["[233705\/Z\/21\/Z]"]}]},{"name":"FCDO\/Wellcome Trust under the Coronavirus Grant","award":["[233705\/Z\/21\/Z]"],"award-info":[{"award-number":["[233705\/Z\/21\/Z]"]}]},{"name":"FCDO\/Wellcome Trust under the Coronavirus Grant","award":["[233705\/Z\/21\/Z]"],"award-info":[{"award-number":["[233705\/Z\/21\/Z]"]}]},{"name":"FCDO\/Wellcome Trust under the Coronavirus Grant","award":["[233705\/Z\/21\/Z]"],"award-info":[{"award-number":["[233705\/Z\/21\/Z]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32045-3","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:06:20Z","timestamp":1765422380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular epidemiology of Plasmodium falciparum drug resistance and vaccine targets in high-transmission settings in Africa"],"prefix":"10.1038","volume":"16","author":[{"given":"I. A.","family":"Aliyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. G.","family":"Amole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Umar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Garba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Gwarzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Hidaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. H.","family":"Aliyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Galadanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"32045_CR1","unstructured":"World Health Organization. World Malaria Report 2022. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022 (WHO, 2023)."},{"issue":"7572","key":"32045_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526 (7572), 207\u2013211. https:\/\/doi.org\/10.1038\/nature15535 (2015).","journal-title":"Nature"},{"key":"32045_CR3","unstructured":"World Health Organization. World Malaria Report 2023. https:\/\/www.who.int\/publications\/malaria-report-2023 (WHO, 2023)."},{"issue":"5","key":"32045_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361 (5), 455\u2013467. https:\/\/doi.org\/10.1056\/NEJMoa0808859 (2009).","journal-title":"N. Engl. J. Med."},{"issue":"7481","key":"32045_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505 (7481), 50\u201355. https:\/\/doi.org\/10.1038\/nature12876 (2014).","journal-title":"Nature"},{"issue":"13","key":"32045_CR6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385 (13), 1163\u20131171. https:\/\/doi.org\/10.1056\/NEJMoa2101746 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"32045_CR7","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D Menard","year":"2016","unstructured":"Menard, D. et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N. Engl. J. Med. 374 (25), 2453\u20132464. https:\/\/doi.org\/10.1056\/NEJMoa1513137 (2016).","journal-title":"N. Engl. J. Med."},{"key":"32045_CR8","doi-asserted-by":"publisher","first-page":"101347","DOI":"10.1016\/j.jacadv.2024.101347","volume":"3","author":"IA Aliyu","year":"2024","unstructured":"Aliyu, I. A. et al. Rheumatic heart disease burden in Africa and the need to build robust infrastructure. JACC Adv. 3, 101347 (2024).","journal-title":"JACC Adv."},{"issue":"3","key":"32045_CR9","doi-asserted-by":"publisher","first-page":"e02382","DOI":"10.1128\/AAC.02382-16","volume":"61","author":"CJ Sutherland","year":"2021","unstructured":"Sutherland, C. J. et al. Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the UK. Antimicrob. Agents Chemother. 61 (3), e02382\u2013e02316. https:\/\/doi.org\/10.1128\/AAC.02382-16 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"32045_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo, I. & Roper, C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019malaria. Trends Parasitol. 29 (10), 505\u2013515 (2013).","journal-title":"Trends Parasitol."},{"key":"32045_CR11","unstructured":"World Health Organization. WHO Guidelines for Malaria, 3 June 2022 (No. WHO\/UCN\/GMP\/2022.01 Rev. 2) (World Health Organization, 2022)."},{"issue":"10287","key":"32045_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","volume":"397","author":"MS Datoo","year":"2021","unstructured":"Datoo, M. S. et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina faso: a randomised controlled trial. Lancet 397 (10287), 1809\u20131818. https:\/\/doi.org\/10.1016\/S0140-6736(21)00943-0 (2021).","journal-title":"Lancet"},{"key":"32045_CR13","unstructured":"World Health Organization. WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk. https:\/\/www.who.int\/news\/item\/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk (2021)."},{"issue":"21","key":"32045_CR14","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","volume":"373","author":"DE Neafsey","year":"2015","unstructured":"Neafsey, D. E. et al. Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine. N. Engl. J. Med. 373 (21), 2025\u20132037. https:\/\/doi.org\/10.1056\/NEJMoa1505819 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"32045_CR15","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","volume":"374","author":"A Olotu","year":"2016","unstructured":"Olotu, A. et al. Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children. N. Engl. J. Med. 374 (26), 2519\u20132529. https:\/\/doi.org\/10.1056\/NEJMoa1515257 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"32045_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jtm\/taad140","volume":"30","author":"B Genton","year":"2023","unstructured":"Genton, B. R21\/Matrix-M\u2122 malaria vaccine: a new tool to achieve who\u2019s goal to eliminate malaria in 30 countries by 2030? J. Travel Med. 30 (8), 140 (2023).","journal-title":"J. Travel Med."},{"issue":"7407","key":"32045_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11174","volume":"487","author":"M Manske","year":"2012","unstructured":"Manske, M. et al. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 487 (7407), 375\u2013379. https:\/\/doi.org\/10.1038\/nature11174 (2012).","journal-title":"Nature"},{"issue":"10","key":"32045_CR18","doi-asserted-by":"publisher","first-page":"a025601","DOI":"10.1101\/cshperspect.a025601","volume":"7","author":"MC Castro","year":"2017","unstructured":"Castro, M. C. Malaria transmission and prospects for malaria eradication: the role of the environment. Cold Spring Harbor Perspect. Med. 7 (10), a025601 (2017).","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"2","key":"32045_CR19","first-page":"149","volume":"10","author":"I Muhammad","year":"2022","unstructured":"Muhammad, I. et al. Determining molecular markers associated with drug resistance in DHFR and DHPS genes of plasmodium falciparum from Gombe LGA Gombe State, Nigeria. Int. J. Adv. Biol. Biomed. Res. 10 (2), 149\u2013163 (2022).","journal-title":"Int. J. Adv. Biol. Biomed. Res."},{"issue":"1","key":"32045_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.54987\/jobimb.v11i1.803","volume":"11","author":"IU Muhammad","year":"2023","unstructured":"Muhammad, I. U., Imam, A. A. & Khadijah, S. Plasmodium falciparum multidrug Resistance-1 (pfmdr1) gene mutation in adults malaria patients attending Murtala Muhammad specialist hospital Kano, Northwest Nigeria. J. Biochem. Microbiol. Biotechnol. 11 (1), 31\u201336 (2023).","journal-title":"J. Biochem. Microbiol. Biotechnol."},{"issue":"2","key":"32045_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.34172\/ajcmi.3524","volume":"11","author":"AA Zubair","year":"2024","unstructured":"Zubair, A. A. et al. Molecular surveillance of Artemisinin combination therapy resistance markers in Kelch13 gene of plasmodium falciparum isolates collected from Yobe state Nigeria. Avicenna J. Clin. Microbiol. Infect. 11 (2), 87\u201396 (2024).","journal-title":"Avicenna J. Clin. Microbiol. Infect."},{"issue":"11","key":"32045_CR22","doi-asserted-by":"publisher","first-page":"e1002992","DOI":"10.1371\/journal.pgen.1002992","volume":"8","author":"A Amambua-Ngwa","year":"2012","unstructured":"Amambua-Ngwa, A. et al. Population genomic scan for candidate signatures of balancing selection to guide antigen characterization in malaria parasites. PLoS Genet. 8 (11), e1002992. https:\/\/doi.org\/10.1371\/journal.pgen.1002992 (2012).","journal-title":"PLoS Genet."},{"issue":"1","key":"32045_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.meegid.2012.10.016","volume":"4","author":"VA Mobegi","year":"2014","unstructured":"Mobegi, V. A. et al. Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations. Parasite Genomics Genet. 4 (1), 1\u201312. https:\/\/doi.org\/10.1016\/j.meegid.2012.10.016 (2014).","journal-title":"Parasite Genomics Genet."},{"issue":"12","key":"32045_CR24","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41564-023-01516-6","volume":"8","author":"ST Girgis","year":"2023","unstructured":"Girgis, S. T. et al. Drug resistance and vaccine target surveillance of plasmodium falciparum using nanopore sequencing in Ghana. Nat. Microbiol. 8 (12), 2365\u20132377 (2023).","journal-title":"Nat. Microbiol."},{"key":"32045_CR25","doi-asserted-by":"publisher","first-page":"e62997","DOI":"10.7554\/eLife.62997","volume":"10","author":"CG Jacob","year":"2021","unstructured":"Jacob, C. G. et al. Genetic surveillance in the greater Mekong subregion and South Asia to support malaria control and elimination. Elife 10, e62997 (2021).","journal-title":"Elife"},{"issue":"5","key":"32045_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(18)30046-X","volume":"18","author":"TN Nguyen","year":"2018","unstructured":"Nguyen, T. N. et al. The persistence and oscillations of submicroscopic plasmodium falciparum and plasmodium Vivax infections over time in vietnam: an open cohort study. Lancet. Infect. Dis. 18 (5), 565\u2013572 (2018).","journal-title":"Lancet. Infect. Dis"},{"key":"32045_CR27","doi-asserted-by":"publisher","first-page":"1346017","DOI":"10.3389\/fpara.2024.1346017","volume":"3","author":"M Maina","year":"2024","unstructured":"Maina, M. et al. Genetic variation of the plasmodium falciparum circumsporozoite protein in parasite isolates from Homabay County in Kenya. Front. Parasitol. 3, 1346017 (2024).","journal-title":"Front. Parasitol."},{"issue":"2","key":"32045_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pt.2018.11.008","volume":"35","author":"K Dundas","year":"2019","unstructured":"Dundas, K., Shears, M. J., Sinnis, P. & Wright, G. J. Important extracellular interactions between plasmodium sporozoites and host cells required for infection. Trends Parasitol. 35 (2), 129\u2013139 (2019).","journal-title":"Trends Parasitol."},{"issue":"7","key":"32045_CR29","doi-asserted-by":"publisher","first-page":"e1006469","DOI":"10.1371\/journal.ppat.1006469","volume":"13","author":"CR Fisher","year":"2017","unstructured":"Fisher, C. R. et al. T-dependent B cell responses to plasmodium induce antibodies that form a high-avidity multivalent complex with the circumsporozoite protein. PLoS Pathog. 13 (7), e1006469 (2017).","journal-title":"PLoS Pathog."},{"issue":"48","key":"32045_CR30","doi-asserted-by":"publisher","first-page":"E10438","DOI":"10.1073\/pnas.1715812114","volume":"114","author":"D Oyen","year":"2017","unstructured":"Oyen, D. et al. Structural basis for antibody recognition of the NANP repeats in plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. 114 (48), E10438\u2013E10445 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"32045_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/587845","volume":"197","author":"C Lynch","year":"2008","unstructured":"Lynch, C. et al. Emergence of a Dhfr mutation conferring high-level drug resistance in plasmodium falciparum populations from Southwest Uganda. J. Infect. Dis. 197 (11), 1598\u20131604 (2008).","journal-title":"J. Infect. Dis."},{"key":"32045_CR32","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.2147\/IDR.S375197","volume":"1","author":"S Nikiema","year":"2022","unstructured":"Nikiema, S. et al. Seasonal malaria chemoprevention implementation: effect on malaria incidence and immunity in a context of expansion of P. falciparum resistant genotypes with potential reduction of the effectiveness in Sub-Saharan Africa. Infect. Drug Resist. 1, 4517\u20134527 (2022).","journal-title":"Infect. Drug Resist."},{"issue":"7","key":"32045_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/infdis\/jiad172","volume":"228","author":"ME Roh","year":"2023","unstructured":"Roh, M. E. et al. Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina faso: a case-control study. J. Infect. Dis. 228 (7), 926\u2013935 (2023).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"32045_CR34","first-page":"175","volume":"21","author":"L Yusuf","year":"2020","unstructured":"Yusuf, L. et al. Phytotherapy as an alternative for the treatment of human papilloma virus infections in nigeria: a review. Afr. J. Clin. Experimental Microbiol. 21 (3), 175\u2013184 (2020).","journal-title":"Afr. J. Clin. Experimental Microbiol."},{"issue":"2","key":"32045_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai, M. et al. Epidemiology and burden of malaria in pregnancy. Lancet. Infect. Dis. 7 (2), 93\u2013104 (2007).","journal-title":"Lancet. Infect. Dis"},{"issue":"1","key":"32045_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13000-015-0276-2","volume":"10","author":"OO Oladipo","year":"2015","unstructured":"Oladipo, O. O., Wellington, O. A. & Sutherland, C. J. Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagn. Pathol. 10 (1), 41 (2015).","journal-title":"Diagn. Pathol."},{"issue":"7","key":"32045_CR37","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3201\/eid2707.203230","volume":"27","author":"SE Schmedes","year":"2021","unstructured":"Schmedes, S. E. et al. Plasmodium falciparum Kelch 13 mutations, 9 countries in Africa, 2014\u20132018. Emerg. Infect. Dis. 27 (7), 1902 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"32045_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03968-9","volume":"20","author":"M Ikegbunam","year":"2021","unstructured":"Ikegbunam, M. et al. Absence of plasmodium falciparum Artemisinin resistance gene mutations eleven years after the adoption of Artemisinin-based combination therapy in Nigeria. Malar. J. 20, 1\u20136 (2021).","journal-title":"Malar. J."},{"issue":"5","key":"32045_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison, S. et al. Independent emergence of Artemisinin resistance mutations among plasmodium falciparum in Southeast Asia. J. Infect. Dis. 211 (5), 670\u2013679. https:\/\/doi.org\/10.1093\/infdis\/jiu491 (2015).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"32045_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41591-021-01221-2","volume":"27","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 27 (3), 592\u2013595. https:\/\/doi.org\/10.1038\/s41591-021-01221-2 (2020).","journal-title":"Nat. Med."},{"issue":"319","key":"32045_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2947-z","volume":"18","author":"AO Idowu","year":"2019","unstructured":"Idowu, A. O. et al. Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria. Malar. J. 18 (319), 1. https:\/\/doi.org\/10.1186\/s12936-019-2947-z (2019).","journal-title":"Malar. J."},{"issue":"1","key":"32045_CR42","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1038\/s41598-017-06708-9","volume":"7","author":"LC Okell","year":"2017","unstructured":"Okell, L. C., Griffin, J. T. & Roper, C. Mapping sulphadoxine-pyrimethamine-resistant plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci. Rep. 7 (1), 7389 (2017).","journal-title":"Sci. Rep."},{"issue":"4","key":"32045_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/tropicalmed8040184","volume":"8","author":"JM Ndong Ngomo","year":"2023","unstructured":"Ndong Ngomo, J. M. et al. Drug resistance molecular markers of plasmodium falciparum and severity of malaria in febrile children in the Sentinel site for malaria surveillance of Melen in gabon: additional data from the plasmodium diversity network African network. Trop. Med. Infect. Disease. 8 (4), 184 (2023).","journal-title":"Trop. Med. Infect. Disease"},{"issue":"1","key":"32045_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot, S. et al. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar. J. 8 (1), 89 (2009).","journal-title":"Malar. J."},{"key":"32045_CR45","unstructured":"World Health Organization. WHO Malaria Policy Advisory Group (MPAG) Meeting Report, 18\u201320 April 2023 (World Health Organization, 2023)."},{"issue":"1","key":"32045_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12936-019-2716-z","volume":"18","author":"M Ocan","year":"2019","unstructured":"Ocan, M. et al. Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors. Malar. J. 18 (1), 76 (2019).","journal-title":"Malar. J."},{"key":"32045_CR47","unstructured":"MalariaGEN. The MalariaGEN Plasmodium Falciparum Community Project: Global Genomic Surveillance Data for Malaria Control and Elimination. https:\/\/www.malariagen.net (MalariaGEN Consortium, 2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32045-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32045-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:03:22Z","timestamp":1769209402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32045-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32045"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32045-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2266"}}